Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

PEG-hirudin more effective than heparin in patients with acute coronary syndromes

Sep. 2, 1998

Canadian authorities approve use of Fragmin in treatment of heart disease

Aug. 31, 1998

BioCryst identifies development candidate in complement inhibitor program

Aug. 28, 1998

Preclinical and clinical data reported for orbofiban, a potent antiplatelet agent

Aug. 28, 1998

AR-C69931MX; a novel P2T antagonist with platelet aggregation-inhibitory activity

Aug. 28, 1998

ACS news flash: R.W. Johnson investigates thrombin inhibitors

Aug. 25, 1998

Eptifibatide treatment reduces incidence of death in acute myocardial infarction and unstable angina

Aug. 25, 1998

Corvas and Schering-Plough discontinue collaboration; other projects remain on track

Aug. 24, 1998

Novel antithrombotic agents added to the pipeline at NicOx

Aug. 17, 1998

Zeneca claims factor Xa inhibitors with antithrombotic/anticoagulant activity

Aug. 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...